Stenabolic Research Overview
Stenabolic (SR-9009) is a Rev-Erbα nuclear receptor agonist developed for metabolic and circadian biology research applications. This compound operates through a unique mechanism distinct from traditional SARMs, targeting Rev-Erbα proteins that regulate circadian rhythm gene expression, mitochondrial biogenesis, and cellular energy metabolism in preclinical models. Researchers at Stroid UK Shop can investigate this compound’s effects on metabolic pathways in controlled laboratory environments.
Laboratory Research Applications
Stenabolic has been extensively studied for its role in metabolic syndrome research and circadian biology investigations. Animal models demonstrate that SR-9009 modulates lipid metabolism, mitochondrial function, and energy expenditure through Rev-Erbα pathway activation. The compound’s influence on circadian rhythm regulation makes it valuable for chronobiology research, while its metabolic effects have been investigated in obesity and metabolic dysfunction studies. Researchers examining stenabolic compounds often focus on its unique mechanism compared to traditional SARMs or peptides used in similar research contexts.
Technical Specifications
| Parameter | Value |
|---|---|
| CAS Number | 1379686-30-2 |
| Molecular Formula | C₂₀H₂₄ClN₃O₄S |
| Molecular Weight | 437.94 g/mol |
| Purity | Verify with supplier |
| Storage Conditions | Room temperature, dry environment |
| Classification | Rev-Erbα agonist |
Research Use Compliance
This Stenabolic preparation from Biogenic Pharma is supplied exclusively for in-vitro laboratory research purposes. The compound is not approved for human consumption, therapeutic use, or any application outside controlled scientific investigation. Researchers must handle this material according to appropriate laboratory safety protocols and institutional guidelines for research chemical handling. All studies should be conducted by qualified personnel in properly equipped laboratory facilities.
